Part 1: Potential Dangers of Extreme Endurance Exercise: How Much Is Too Much? Part 2: Screening of School-Age Athletes

Progress in Cardiovascular Diseases

Volumn 57, Issue 4, 2015, Pages 396-405

  O'Keefe, James H ^a   Lavie, Carl J ^b,c   Guazzi, Marco ^d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Atrial fibrillation; Cardiovascular; Exercise; Longevity; Physical activity; Running

Indexed keywords

AEROBIC EXERCISE; ARTICLE; ATHLETE; CARDIAC OVERUSE INJURY; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR MORTALITY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENDURANCE TRAINING; EXERCISE INTENSITY; EXTREME SPORT; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JOGGING; LONG QT SYNDROME; LONGEVITY; MARATHON RUNNER; MARFAN SYNDROME; NONHUMAN; PHYSICAL ACTIVITY; RUNNING; SCREENING; SKIING; WALKING; WOLFF PARKINSON WHITE SYNDROME; ATHLETIC INJURIES; CAUSE OF DEATH; ENDURANCE; EXERCISE; HARM REDUCTION; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; POPULATION; RISK; SPORT; STATISTICS AND NUMERICAL DATA; TIME;

ATHLETES; ATHLETIC INJURIES; CAUSE OF DEATH; EXERCISE; HARM REDUCTION; HUMANS; PHYSICAL ENDURANCE; POPULATION; RISK; SPORTS; TIME;

EID: 84920171919     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.11.004     Document Type: Article

References (50)

1. Williams P., Thompson P. Increased cardiovascular disease mortality from excessive exercise in heart attack survivors. Mayo Clin Proc 2014, 89(9):1187-1194.
2. Mons U., Hahmann H., Brenner H. A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements. Heart 2014, 100(13):1043-1049.
3. O'Keefe J.H., Patil H.R., Lavie C.J., Magalski A., Vogel R.A., McCullough P.A. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 2012, 87(6):587-595.
4. O'Keefe J.H., Franklin B., Lavie C.J. Exercising for health and longevity vs peak performance: different regimens for different goals. Mayo Clin Proc 2014, 89(9):1171-1175.
5. Swift D.L., Lavie C.J., Johannsen N.M., et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 2013, 77(2):281-292.
6. Blair S.N., Kohl H.W., Paffenbarger R.S., Clark D.G., Cooper K.H., Gibbons L.W. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262(17):2395-2401.
7. Kokkinos P., Myers J. Exercise and physical activity: clinical outcomes and applications. Circulation 2010, 122(16):1637-1648.
8. Trivax J.E., Franklin B.A., Goldstein J.A., et al. Acute cardiac effects of marathon running. J Appl Physiol 2010, 108(5):1148-1153.
9. Mohlenkamp S., Leineweber K., Lehmann N., et al. Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners. Basic Res Cardiol 2014, 109(1):391.
10. O'Keefe J.H., Lavie C.J. Run for your life... at a comfortable speed and not too far. Heart 2013, 99(8):516-519.
11. O'Keefe J.H., Schnohr P., Lavie C.J. The dose of running that best confers longevity. Heart 2013, 99(8):588-590.
12. O'Keefe J.H., Patil H., Magalski A., Lavie C.J., Vogel R.A., McCullough P.A. Reply to Letter to the Editor: potential, but unobserved, adverse cardiovascular effects from endurance exercise. Mayo Clin Proc 2012, 87(11):1132-1134.
13. Lee D.-C., Pate R.R., Lavie C.J., Sui X., Church T.S., Blair S.N. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol 2014, 64(5):472-481.
14. Schnohr P., O'Keefe J.H., Marott J.L., Lange P., Jensen G.B. Dose of jogging and long term mortality-the Copenhagen City Heart Study. J Am Coll Cardiol 2014, [In Press].
15. Andersen K., Farahmand B., Ahlbom A., et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J 2013, 34(47):3624-3631.
16. Menezes A.R., Lavie C.J., DiNicolantonio J.J., et al. Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc 2013, 88(4):394-409.
17. Drca N., Wolk A., Jensen-Urstad M., Larsson S.C. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart 2014, 100(13):1037-1042.
18. Mozaffarian D., Furberg C.D., Psaty B.M., Siscovick D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 2008, 118(8):800-807.
19. Wilhelm M., Roten L., Tanner H., Wilhelm I., Schmid J.P., Saner H. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol 2011, 108(4):580-585.
20. Kim J.H., Malhotra R., Chiampas G., et al. Cardiac arrest during long-distance running races. N Engl J Med 2012, 366(2):130-140.
21. Schwartz R.S., Merkel Kraus S., J.G.S, et al. Increased coronary artery plaque volume among male marathon runners. Mo Med 2014, 111(2):85-90.
22. Deaner R.O., Carter R.E., Joyner M.J., Hunter S.K. Men are more likely than women to slow in the marathon. Med Sci Sports Exerc 2014.
23. Bhella P.S., Hastings J.L., Fujimoto N., et al. Impact of lifelong exercise "dose" on left ventricular compliance and distensibility. J Am Coll Cardiol 2014, 64(12):1257-1266.
24. Freund W., Faust S., Birklein F., et al. Substantial and reversible brain gray matter reduction but no acute brain lesions in ultramarathon runners: experience from the TransEurope-FootRace Project. BMC Med 2012, 10:170.
25. Donato S. 10 Toughest Endurance Races in the World 2013, http://www.huffingtonpost.com/kensington-explorersinresidence/toughest-races_b_4123737.html., Huffington Post Travel, [October 28, 2013. Accessed October 2, 2014].
26. Han X.G., Small D.S., Foster D.P., Patel V. The effect of winning an Oscar Award on survival: correcting for healthy performer survivor bias with a rank preserving structural accelerated failure time model. Ann Appl Stat 2011, 5(2A):746-772.
27. Michaelides A.P., Soulis D., Antoniades C., et al. Exercise duration as a determinant of vascular function and antioxidant balance in patients with coronary artery disease. Heart 2011, 97(10):832-837.
28. Nassenstein K., Breuckmann F., Lehmann N., et al. Left ventricular volumes and mass in marathon runners and their association with cardiovascular risk factors. Int J Cardiovasc Imaging 2009, 25(1):71-79.
29. La Gerche A., Burns A.T., Mooney D.J., et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2011.
30. Ector J., Ganame J., van der Merwe N., et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J 2007, 28(3):345-353.
31. Heidbuchel H., Hoogsteen J., Fagard R., et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 2003, 24(16):1473-1480.
32. Sharma S., Zaidi A. Exercise-induced arrhythmogenic right ventricular cardiomyopathy: fact or fallacy?. Eur Heart J 2011.
33. Benito B., Gay-Jordi G., Serrano-Mollar A., et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011, 123(1):13-22.
34. Breuckmann F., Mohlenkamp S., Nassenstein K., et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 2009, 251(1):50-57.
35. Redelmeier D.A., Greenwald J.A. Competing risks of mortality with marathons: retrospective analysis. BMJ 2007, 335(7633):1275-1277.
36. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008, 51(8):802-809.
37. Biffi A., Pelliccia A., Verdile L., et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002, 40(3):446-452.
38. Spirito P., Pelliccia A., Proschan M.A., et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994, 74(8):802-806.
39. Oxborough D., Birch K., Shave R., George K. Exercise-induced cardiac fatigue-a review of the echocardiographic literature. Echocardiography 2010, 27(9):1130-1140.
40. La Gerche A., Heidbuchel H. Can intensive exercise harm the heart? You can get too much of a good thing. Circulation 2014, 130(12):992-1002.
41. Adult participation in aerobic and muscle-strengthening physical activities-United States, 2011. MMWR Morb Mortal Wkly Rep 2013, 62(17):326-330.
42. La Gerche A., Prior D.L. Exercise-is it possible to have too much of a good thing?. Heart Lung Circ 2007, 16(Suppl. 3):S102-S104.
43. Corrado D., Basso C., Pavei A., Michieli P., Schiavon M., Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006, 296(13):1593-1601.
44. Maron B.J., Doerer J.J., Haas T.S., Tierney D.M., Mueller F.O. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009, 119(8):1085-1092.
45. Maron B.J., Haas T.S., Doerer J.J., Thompson P.D., Hodges J.S. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009, 104(2):276-280.
46. Steinvil A., Chundadze T., Zeltser D., et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking?. J Am Coll Cardiol 2011, 57(11):1291-1296.
47. Pelliccia A., Zipes D.P., Maron B.J. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008, 52(24):1990-1996.
48. Telushkin J. Jewish literacy: the most important things to know about the Jewish religion, its people, and its history 1991, William Morrow, New York City. 1st ed.
49. Corrado D., Basso C., Schiavon M., Pelliccia A., Thiene G. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol 2008, 52(24):1981-1989.
50. Maron B.J., Thompson P.D., Ackerman M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007, 115(12):1643-1455.